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The Avon Longitudinal Study of Parents and Children (ALSPAC) is a
transgenerational prospective observational study investigating influ-
ences on health and development across the life course. It considers
multiple genetic, epigenetic, biological, psychological, social and other
environmental exposures in relation to a similarly diverse range of
health, social and developmental outcomes. Recruitment sought to
enrol pregnant women in the Bristol area of the UK during 1990–92;
this was extended to include additional children eligible using the
original enrolment definition up to the age of 18 years. The children
from 14 541 pregnancies were recruited in 1990–92, increasing to
15 247 pregnancies by the age of 18 years. This cohort profile describes
the index children of these pregnancies. Follow-up includes 59 ques-
tionnaires (4 weeks–18 years of age) and 9 clinical assessment visits
(7–17 years of age). The resource comprises a wide range of phenotypic
and environmental measures in addition to biological samples, genetic
(DNA on 11 343 children, genome-wide data on 8365 children, com-
plete genome sequencing on 2000 children) and epigenetic (methyla-
tion sampling on 1000 children) information and linkage to health
and administrative records. Data access is described in this article and
is currently set up as a supported access resource. To date, over 700
peer-reviewed articles have been published using ALSPAC data.
Why was the cohort set up?
The Avon Longitudinal Study of Parents and Children,
known to its participants as ‘Children of the 90s’
(Figure 1), originated in a WHO Europe sponsored
meeting held in Moscow in 1985 recommending the
establishment of birth cohort studies across Europe to
investigate modifiable influences on child health and
development. Jean Golding subsequently designed the
methodology1 for the European Longitudinal Study of
Pregnancy and Childhood (ELSPAC),2 a pan-
European series of longitudinal birth cohorts. The
Avon Longitudinal Study of Parents and Children,
centred on the city of Bristol in the South West of
England, was one of these cohorts. The ALSPAC acro-
nym originally denoted the ‘Avon Longitudinal Study
of Pregnancy and Childhood’ reflecting the original
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study focus. As follow-up beyond early childhood was
developed, ALSPAC was renamed the ‘Avon
Longitudinal Study of ‘‘Parents and Children’’ ’ to re-
flect the continuing importance of the parents as well
as the children.
WHO Europe provided seed funding to develop the
common ELSPAC methodology and to undertake
pilots of the questionnaires in the UK, Russia and
Greece. Subsequently, early funding for ALSPAC was
obtained from various sources, including UK
Government Departments, the UK Medical Research
Council (MRC) and various charities such as the
Wellcome Trust, British Heart Foundation, British
Lung Foundation and Action Research among many
others. North American funding was also obtained,
including from several of the National Institutes of
Health, and the March of Dimes. The University of
Bristol has provided continual support for ALSPAC
from soon after the onset of the study; since 2000,
this support has been augmented by substantial stra-
tegic funding jointly from the Wellcome Trust and the
MRC. Additional support for ALSPAC has come
through programme and project grant funding from
many sources,3 and is listed along with other study
information on the ALSPAC website—http://www
.bristol.ac.uk/alspac/.
This cohort profile describes recruitment and the
first 18 years of follow-up of the ‘Children of the
90s’, i.e. the children of the mothers eligible for re-
cruitment during 1990–92. Recruitment and follow-up
of the mothers is described in a companion article.4
Participants are now in early adulthood; however, the
intention is for follow-up to be lifelong. The transge-
nerational and family-based nature of ALSPAC is
being consolidated through the ALSPAC ‘Focus on
Mothers’ mothers study, the ‘Focus on Fathers’
fathers study and follow-up of the next ALSPAC gen-
eration (ALSPAC-G2 study) through ‘COCO90s’
(Children of Children of the 90s). These initiatives
are not described further here.
Who is in the cohort?
All pregnant women residents in that part of the old
administrative county of Avon comprising the three
Health Districts shown in Figure 2 were eligible to
participate in ALSPAC if their estimated delivery
date (EDD) fell between 1 April 1991 and 31
December 1992 inclusive. Any resulting child from
these pregnancies is considered eligible. The catch-
ment area covered the three health administration
districts within the South-West Regional Health
Authority that became the ‘Bristol & District Health
Authority’. This area (1991 total population 0.9 mil-
lion) includes the City of Bristol (1991 population
0.5 million) and surrounding urban and rural
areas, including towns, villages and farming commu-
nities; but excludes the area of Avon around the City
of Bath. Pregnant women migrating into the catch-
ment area were eligible up to the point of delivery;
pregnant women originally resident in Avon but
migrating out of the catchment area prior to delivery
were excluded unless they had completed the ques-
tionnaire scheduled for the third trimester of preg-
nancy. A small number of women and their
children falling outside the above strict definition of
eligibility contributed data and have been included in
ALSPAC. This is discussed below.
ALSPAC recruitment campaign
Recruitment to ALSPAC was opportunistic and aimed
to recruit women as early in pregnancy as possible.
ALSPAC attempted to make contact with eligible
women through media information encouraging
study contact and recruitment staff visiting commu-
nity locations. In parallel, routine antenatal and ma-
ternity health services were used to promote the study
and distribute an ‘expression of interest’ card.
Through returning this card, women were able to re-
quest further information on the study or to decline
participation. Completed cards contained sufficient
detail (address and EDD) to allow ALSPAC staff to
determine eligibility. Women requesting further infor-
mation were sent a study information booklet fol-
lowed by an initial questionnaire 1 week later.





Figure 1 The life course of the ALSPAC Study Logo










‘opt out’, i.e. women not actively declining participa-
tion would be included in future data collection
follow-up.
ALSPAC eligible sample
During the 1990–92 recruitment campaign, the
ALSPAC target sample was a dynamic population for
whom no convenient sampling frame to support sys-
tematic invitation of all eligible individuals was avail-
able. The eligible study sample has been defined
retrospectively, based on ALSPAC recruitment records
and maternity, birth and child health records.5
Comparing these health records with ALSPAC study
records, we are able to describe study recruitment
(Figure 3). Recruitment was not complete, which is
unsurprising given its opportunistic nature. It is
impossible to fully ascertain retrospectively where
non-recruitment represents failure to invite as
opposed to active non-response. Records of the re-
turned expression of interest cards and the proportion
of these women declining participation are known
(Figure 3); however, the number of invitation cards
distributed is unknown. The methods used in
retrospectively defining the cohort allowed the use
of more accurate geocoding resources, unavailable to
recruiters in the early 1990s. These resources identi-
fied 229 pregnancies (233 children), living on the geo-
graphical periphery of the study area, that were
incorrectly assumed to be eligible in 1990–92. As
these individuals enrolled and contributed data, we
have continued to include them in both the ‘eligible
sample’ and the ‘enrolled sample’; as such they are
eligible for continuing follow-up and are included in
all figures provided in this article.
Recruitment outwith the period 1990–92
The substantial majority (82.6%) of women are
known to have been invited to enrol during the
1990–92 recruitment campaign. Subsequent work to
define the ‘eligible sample’ identified additional preg-
nancies where the offspring were eligible for recruit-
ment, but no replies to recruitment in 1990–92 had
been received (either positive or negative). With fund-
ing to complete a ‘Focus@7’ follow-up assessment of
all of the participants at 7 years of age, the opportun-
ity was taken to attempt to recruit all known eligible
Figure 2 The ALSPAC Eligible Study Area; the study area within the UK and details illustrating the three eligible NHS
District Health Authorities (DHAs).  Crown Copyright/database right 2011. An Ordnance Survey/EDINA supplied service










Figure 3 The ALSPAC enrolment campaign flow diagram










children who would have fitted the original eligibility
criteria, excluding those who had previously refused
enrolment. Invitations describing the study were sent
to this group, inviting the mothers to enrol (recruit-
ment Phase II in Figure 3). In addition to this sys-
tematic recruitment, ALSPAC made subsequent
opportunistic contact with additional families who
were ‘eligible’ but not ‘enrolled’ (recruitment Phase
III in Figure 3). Contact was initiated by eligible
families seeking enrolment or during ALSPAC com-
munity outreach and promotion activities. Due to
the nature of these recruitment methods, it is not
possible to determine how many individuals were
‘invited’ during recruitment Phases II and III. Where
recruitment occurred in Phases II and III, ALSPAC
have not been able to collect the pregnancy, infancy
and early childhood data that were collected from
parental self-completed questionnaires from the
sample recruited during pregnancy (Phase I).
ALSPAC recruitment rates
The ‘eligible sample’ comprises 20 248 pregnancies.
The mothers of 14 541 (71.8%) pregnancies were re-
cruited antenatally during 1990–92 (recruitment
Phase I). Of these 14 541 pregnancies, 68 have no
known birth outcome; of the remaining 14 472 preg-
nancies, 195 were twin, 3 were triplet and 1 was quad-
ruplet, meaning that there are 14 676 known foetuses.
These pregnancies resulted in 14 062 live-born children
of whom 13 988 were alive at 1 year of age. Post-natal
recruitment to the ‘Focus@7’ clinical assessment at
the age of 7 years recruited a further 456 children
from 452 (2.2% of eligible) pregnancies (Phase II).
Recruitment during Phase III (ages 8–18 years)
added a further 257 children from 254 (1.2% of eli-
gible) pregnancies, giving an overall total of 15 247
(75.3% of eligible) enrolled pregnancies; from these
pregnancies there were 14 775 live-born children of
which 14 701 were alive at one year of age (Table 1).
The birth outcomes of the 20 248 eligible pregnancies
are detailed in Table 1; this information is based on
ALSPAC recruitment records and maternity, birth and
child health records. The full extent of miscarriage
(foetal loss prior to 20 weeks of gestation) is likely
to be under-represented in both the 1990–92 ALSPAC
recruitment records and the records used to identify
the eligible sample. Of the 20 390 known foetuses,
the birth outcomes include 19 600 (96.1%) live births,
685 (3.4%) miscarriages and 105 (0.5%) stillbirths
(defined as foetal loss after 20 weeks of gestation and
stillborn deliveries). There are an additional 116 preg-
nancies with no known birth outcome. The ‘Children of
the 90s’ ‘enrolled sample’ consists of 14 775 (75.7% of
the 19 600 eligible live births) live-born children from
the 15 247 pregnancies (15 458 foetuses) where an in-
dividual, either the mother/primary caregiver or the
Table 1 ALSPAC eligible sample pregnancy size and birth outcomes
ALSPAC enrolled pregnancies n¼ 15 247 Non-enrolled pregnancies n¼ 5001
ALSPAC eligible sample n¼ 20 248 pregnancies
Pregnancy size n (%)
Singletons 14 971 (98.2)a 4909 (98.2)b
Sets of Twins 204 (1.3)a 43 (0.9)b
Sets of Triplets 3 (<0.1)a 1 (<0.1)b
Sets of Quads 1 (<0.1)a 0 (<0.1)b
No known birth outcome 68 (0.4)a 48 (1.0)b
ALSPAC eligible sample n¼ 20 390 children/foetuses
Outcomes (numbers of foetuses/offspring) n (%)
Foetal loss <20 weeks 547 (3.6)c 138 (2.8)d
Foetal death/sb 20þ weeks 68 (0.4)c 37 (0.7)d
Neonatal death <7 days 45 (0.3)c 11 (0.2)d
Neonatal death 7–27 days 8 (<0.1)c 2 (<0.1)d
Post-neonatal death 28 days–1 year 21 (0.1)c 15 (0.3)d
Alive4 1 year 14 701 (95.5)c 4797 (96.0)d
Total 15 390e (100)c 5000e (100)d
aPercentage of 15 247 enrolled pregnancies.
bPercentage of 5001 non-enrolled pregnancies.
cPercentage of 15 390 enrolled children (foetuses).
dPercentage of 5000 non-enrolled children (foetuses).
eThe sample contains two twin pregnancies where only one child enrolled (recruitment phases II and III). These are reported as an
enrolled twin pregnancy with birth outcomes of a single enrolled and a single non-enrolled child.










child, has provided data. Of these enrolled participants,
ALSPAC has collected data relating directly to 14 009
(71.5% of 19 600 eligible live births) children, through
self-reported data from the child or data provided
about the child by the biological mother/primary care-
giver. The ‘eligible sample’ remains eligible regardless
of their participation history or movement away
from the study area (questionnaires and invitation to
clinical assessments are sent worldwide); if partici-
pants withdraw from the study, they remain eligible
and are free to re-enrol into the study if they wish
(32 families re-joined the study in this way by the
age of 18 years).
External validity and possible participation
biases
The regional basis of ALSPAC has brought advantages
both in logistics and in the creation and maintenance
of a study identity; however, these advantages may
have been offset by limitations in external validity
when generalizing ALSPAC findings to the national
population. Moreover, as recruitment of eligible
mothers to ALSPAC was incomplete, it is possible
that systematic differences between those recruited
and those not recruited may introduce bias to subse-
quent estimates based on participants.
In the companion article based on ALSPAC mothers,
comparisons of socio-economic characteristics
between the original recruited ALSPAC mothers,
mothers of a child of similar age living in Avon at
the time of ALSPAC initiation and mothers living any-
where in the UK are shown.4 Here we present com-
parisons of demographic and standard school
assessment data, typically taken at 16 years of age,
between a national sample, the ALSPAC ‘enrolled
sample’ and individuals with different enrolment,
participation and study attrition histories (Tables
2–5). The data are taken from the National Pupil
Database (NPD) ‘Key Stage 4’ (KS4) dataset, record-
ing pupil census and assessment data for all pupils in
English schools. Of these, 14 878 ‘eligible’ children
have been linked to a subset of the NPD KS4 records
that relate to government-maintained establishments
(GMEs). As such, this offers the best available, yet
not complete, comparison group (see footnotes in
Table 2).
Comparisons (Table 2) show that those children in
the ALSPAC ‘enrolled sample’ have a higher educa-
tional attainment at the age of 16 years than the NPD
KS4 GME national sample, a difference that is not
present when comparing the ALSPAC ‘eligible
sample’ (mean attainment score of 309, data not
shown) with the NPD KS4 GME national sample.
This difference in mean attainment increases with
increasing completeness of participation in ALSPAC;
conversely children who have not recently partici-
pated or are lost to follow-up through study attrition
have a lower educational attainment than the na-
tional average. The ALSPAC ‘enrolled sample’
(Table 3) are more likely to be White and less likely
to be eligible for free school meals than the NPD KS4
GME national sample. Recent responders (Table 4)
are more likely to be female, White and less likely
to be eligible for free school meals, whereas those
lost to attrition (Table 5) are more likely to be male
and eligible for free school meals.
To an extent the differences in ethnic composition
identified in the comparison between the ALSPAC
Table 2 A comparison of academic attainment between the national NPDa sample and ALSPAC children who have
enrolled, have recently participated or are lost to follow-up
Comparative
indicator











future follow-up Lost to attrition
Academic attainmentat the age of 16 yearse
n 1 759 174 11 008 5473 5535 9452 1556
Mean score 308 317 287 347 324 278
IQR (25–75) 266–374 280–380 242–350 314–398 290–380 224–350
aNPD KS4 GME: The National Pupil Database (NPD) ‘Key Stage 4’ (KS4) dataset records, pupil census and assessment data for all
pupils in English schools at the mean age of 16 years. ALSPAC has linked 14 878 ‘eligible’ children to a subset of the NPD KS4
records that relate to government-maintained establishments (GME). This NPD KS4 GME sample has a 89.5% coverage of all
English pupils nationally and 84.3% regionally (the area including and surrounding the cities of Bristol and Bath). The NPD GME
excludes privately funded and specialist care establishments and as such offers the best available, yet not complete, comparison
group. The majority of the remaining ALSPAC ‘eligible sample’ whom we have not linked to the NPD KS4 GME are thought to live
outside England or relate to individuals where there is insufficient information to establish accurate linkage.
bAll pupils, excluding those in ALSPAC, from English GMEs who sat their KS4 assessments during the same academic years as the
ALSPAC cohort (academic years 2007–09).
cAll pupils, from English GMEs, who are from families that have enrolled in ALSPAC by completing an ALSPAC questionnaire or
clinical assessment.
dAll pupils, from English GMEs, who completed an ALSPAC assessment in the ‘transition to adulthood’ phase (completed a ‘CCS’
or ‘CCXC’ questionnaire or attended the TF17 Focus clinical assessment).
eAcademic attainment at the age of 16 years (total points score for the pupils eight highest scoring assessments).










‘enrolled sample’ and the national NPD KS4 GME
sample can be attributed to regional differences and
demographic changes within the UK since the birth of
the cohort. The 1991 census data report that 4.1% of
mothers with infants <1 year of age resident in Avon,
described themselves as ‘non-White’, compared with
7.6% of mothers across the whole of Britain.
Nationally, 14.0% of pupils in the NPD KS4 GME data
are described as non-White compared with 8.0% of
pupils regionally. In economic terms, the South West
of England, which incorporates the ALSPAC catchment
area, has a similar gross disposable household income
per head (£13 300) to the English average (£13 500).
This, however, masks regional differences; using the
same measure, the South West ranks fourth highest
of the 12 UK regions.6
Although these data are accurate at the time of writ-
ing ALSPACs, initiatives to address incomplete partici-
pation, described later in the article, are intended to
address these biases and may result in changes in
these results.
How often have they been
followed up?
Assessments have been administered frequently, with
68 data collection time points between birth and 18
Table 3 A comparison of socio-demographic characteristics between the National NPD sample and children who have







n/n (%) n/n (%) OR (95% CI) P4chi2z
Child sex Female 871 375/1 770 654 (49.21) 5470/11 008 (49.69) 1.02 (0.98–1.06) 0.313
Child ethnicity White 1 508 926/1 744 429 (86.50) 10 505/10 933 (96.09) 3.85 (3.50–4.24) <0.001
Low household income FSMc 218 033/1 745 353 (12.49) 682/10 959 (6.22) 0.46 (0.43–0.50) <0.001
aAll pupils, excluding those in ALSPAC, from English GMEs who sat their KS4 assessments during the same academic years as the
ALSPAC cohort (academic years 2007–09).
bAll pupils, from English GMEs, who are from families that have enrolled in ALSPAC by completing an ALSPAC questionnaire or
clinical assessment.
cEligible for ‘free school meals’ (FSM), indicating a joint parental income of 4£16 000.7
zChi-squared test for homogeneity (equal odds).
Table 5 A comparison of socio-demographic characteristics between those children lost to attrition and those who remain








n/n (%) n/n (%) OR (95% CI) P4chi2z
Child sex Female 5 470/11 008 (49.69) 726/1556 (46.66) 0.86 (0.77–0.96) 0.010
Child ethnicity White 10 505/10 933 (96.09) 1473/1545 (95.34) 0.81 (0.62–1.05) 0.103
Low household income FSMb 682/10 959 (6.22) 177/1544 (11.46) 2.28 (1.91–2.74) <0.001
aAll pupils, from English GMEs, who are from families that have enrolled in ALSPAC by completing an ALSPAC questionnaire or
clinical assessment.
bEligible for ‘free school meals’ (FSM), indicating a joint parental income of 4£16 000.7
zChi-squared test for homogeneity (equal odds).
Table 4 A comparison of socio-demographic characteristics between those children who did and did not participate in the
16–18-year data collection assessments
Characteristic Category
Enrolled in ALSPACa Recently participated
Odds ratio
n/n (%) n/n (%) OR (95% CI) P4chi2z
Child sex Female 5470/11 008 (49.69) 3181/5535 (57.47) 1.88 (1.74–2.03) <0.001
Child ethnicity White 10 505/10 933 (96.09) 5322/5508 (96.62) 1.34 (1.10–1.62) 0.004
Low household income FSMb 682/10 959 (6.22) 240/5519 (4.35) 0.51 (0.44–0.60) <0.001
aAll pupils, from English GMEs, who are from families that have enrolled in ALSPAC by completing an ALSPAC questionnaire or
clinical assessment.
bEligible for ‘free school meals’ (FSM), indicating a joint parental income of 4£16 000.7
zChi-squared test for homogeneity (equal odds).










years of age (Supplementary Table S1, available as
Supplementary data at IJE online). These include 34
child-completed questionnaires (CCQs, 25 including
multiple domains and 9 focusing on pubertal devel-
opment), 9 ‘focus’ clinical assessments and 25 ques-
tionnaires about the child completed by the mother or
other main caregiver (MCQs). To aid the clarity of our
reporting, we have retrospectively allocated each data
collection into six phases (Supplementary Table S1a–f,
available as Supplementary data at IJE online); ‘in-
fancy’ (54 weeks and 42 years of age), ‘early child-
hood’ (42 years and <7 years), ‘childhood’ (7 years of
age), ‘late childhood’ (47 years and <13 years), ‘ado-
lescence’ (513 years and <16 years) and ‘transition
to adulthood’ (416 years and 418 years). The ‘in-
fancy’ phase included four MCQs and a subsample,
selected from the past 6 months of ALSPAC births,
who were invited to the first four ‘Children in
Focus’ (CiF) study assessment clinics. ‘Early child-
hood’ included 11 MCQs, 6 CCQs and the CiF sub-
sample who were invited to a further 6 clinical
assessments. ‘Childhood’ included the first focus
(‘Focus@7’) study assessment clinic and one CCQ.
‘Late childhood’ included six MCQs, nine CCQs and
four ‘Focus’ clinics. ‘Adolescence’ included three
MCQs, seven CCQs and two ‘Focus’ clinics and finally
‘transition to adulthood’ included one MCQ, two
CCQs and the latest clinic assessment visit
(‘Focus@17’). The enrolled sample was increased in
‘childhood’ through recruitment Phase II, and recruit-
ment Phase III ran from ‘late childhood’ through
‘transition to adulthood’ inclusive.
Additional follow-up of the ‘eligible sample’ has been
made through school-administered questionnaires and
assessments completed by the child’s teacher. There
have been numerous subpopulation studies using quan-
titative and qualitative methodologies that are
described later in this article. The ‘eligible sample’
have been linked to National Health Service (NHS)
death and cancer registries (99% linkage match rate)
and education attainment and school census data
(82% linkage match rate, reflecting that only English
GME schools are available; this excludes private educa-
tion that has a 15.7% coverage locally). Both the partici-
pant’s home and school addresses have been geocoded
to a national reference table,8 which allows onward
linkage to neighbourhood socio-demographic and en-
vironmental exposure indicators.
What is attrition like?
Response rates to each data collection are summarized
in Supplementary Table S1 (available as
Supplementary data at IJE online) and Figures 4
and 5. Attrition rates were at their greatest when
the child was in infancy and are increasing again as
the children enter adulthood. The response rates sug-
gest selective participation among respondents with a
larger group of ‘active’ participants than the response
to any single data collection would suggest; e.g. the
average response rate to the 12 measures during the
‘adolescence’ phase is 6155 (48.2% of the 12 776 eli-
gible for follow-up during this phase); however, 9600
(75% of 12 776) individuals responded at least once
Figure 4 Response rates to mother/primary carer completed questionnaires about the child (assessments from 4 weeks old
to 18 years of age)










during this phase (Supplementary Table S1, available
as Supplementary data at IJE online).
A defining feature of the ALSPAC data set is the
breadth of repeat measures taken at frequent intervals
across the life course. Loss to follow-up caused by
permanent attrition to the study (Figure 6) reduces
the proportion of the sample who are eligible for
follow-up at each time point. In addition, the fluctu-
ations in response described previously decreases the
participating sample that consistently responds
(Figure 7). While these factors impact on the avail-
ability of repeat measures across all time points, a
core sub-sample of over 3000 families have responded
to all the 55 assessments open to the ‘full’ sample
(defined in the footnotes to Figure 7) and 5777
have responded to 75% or more of these assessments
(541 individual assessments).
We are addressing incomplete participation in sev-
eral ways. We are conducting a postal campaign seek-
ing consent to collect data from health and
administrative sources (described later) and inviting
re-enrolment in ALSPAC by participants who have
now reached the age of 18 years. We plan to extend
this campaign to eligible individuals who have never
previously participated. We are currently seeking sup-
port under Section 251 of the NHS Act (2006) to col-
lect routine data on non-responders to this campaign.
Through data linkage, we can increase the complete-
ness of the study data set in participants and better
characterize non-participants in order to investigate
possible participation biases. Linkage offers additional
benefits through providing data to inform ALSPAC’s
efforts to fully trace all enrolled participants. We con-
tinue to engage the sample through new media,
including a study children’s Facebook page, and
through targeted community engagement and data
collection. These initiatives and key ALSPAC develop-
ments are developed in consultation with cohort par-
ticipants through an advisory committee (ALSPAC
Teenage Advisory Panel, TAP), participant representa-
tion on the ALSPAC Ethics and Law Committee and
participant focus groups.
What has been measured?
The ALSPAC resource has a scale and richness that is
unprecedented in epidemiological studies. The re-
source contains key phenotypes, genetic and biological
samples collected at multiple time points allowing the
assessment of developmental trajectories and critical
periods of development. Current data collection
focuses on the children’s transition into adulthood,
obtaining measures as the children reach their phys-
ical maxima and observing emerging patterns in risk
Figure 5 Response rates to child study clinical assessments (excluding CiF sub-sample clinics) and self-completed ques-
tionnaires (assessments from 65 months to 18 years). aCCXB questionnaire was administered to a subsample of the cohort.
bCCXC questionnaire piloted a new internet-based data collection and did not receive the normal reminder follow-up
procedure










taking and anti-social behaviour. Measures have been
selected to record the antecedent exposures of future
health and psychosocial outcomes. A comprehensive
guide can be found on our website.9 Key measures are
summarized in Tables 6 and 7.
The ALSPAC phenotype resource
The phenotype resource (Table 6) and environmental
data (Table 7) comprise self-completed child, mother
and teacher questionnaires as well as clinical
assessments.
Figure 6 ALSPAC Study attritiona flow diagram. aIndividuals excluded from follow-up due to a ‘permanent’ status change
that remained in place up to the age of 18 years (e.g. individuals became untraceable and were not found again before the
age of 18 years). Individuals for whom a change in status meant they were temporarily excluded from follow-up are not
included and, therefore, this diagram under-represents attrition at individual data collection time points. bPost-18-year age
tracing and recruitment initiatives in ALSPAC may result in some individuals being included in future follow-up











Since early pregnancy, mothers and children have
provided biological samples including blood, urine,
hair, toenails, teeth, saliva and placenta. To ensure
maximum efficiency of sample use, each sample has
been divided into small aliquots and stored to ensure
long-term preservation. The biobank is summarized in
Supplementary Table S2 (available as Supplementary
data at IJE online); full details of the ALSPAC bio-
bank including a list of child samples and the assayed
results are available on the study website.9
The ALSPAC genetic resource
DNA samples for 11 343 of the children have been
collected, and 6902 of these have had a lymphoblas-
toid cell line transformed to date. The intention is to
collect buccal saliva samples from children with no
existing DNA data. Genome-wide data have been ob-
tained for 8365 of the children. A list of 700 geno-
types assayed on the available 410 000 participants
with DNA samples are on the ALSPAC website.10
Most of these were obtained before genome-
wide data became available, but some represent vari-
ants not included or imputable from genome-wide
data.
A subsample of 2000 of the most heavily pheno-
typed participants will have complete genome sequen-
cing to 6-fold depth (UK10K and Sanger Institute).
For 1000 participants, ALSPAC has obtained gene ex-
pression data (Illumina 48 k chip) and copy number
variation data (custom 105 k Agilent CGH chip from
the WTCCC). DNA methylation data sampling
(Illumina HumanMethylation450 BeadChip) is being
run on 1000 mother and child pairs (where mother
and child DNA is available from all of the following:
child DNA at birth, 7 or 9 mean years of age and 15
or 17 mean years of age and mother DNA from preg-
nancy and child aged 15–17 years); and also
whole-methylome sequencing is currently being
piloted.
Figure 7 ALSPAC assessment response across multiple data collection time points. (a) Response to all 55* child-based
questionnaires and ‘Focus’ clinical assessments across multiple time points. Number of questionnaires about the child
(completed by the child or by the child’s mother/carer) or Focus clinical assessments completed by the child (excludes CiF
sub-sample clinics and the puberty, CCXB and CCXC subsample questionnaire assessments). (b) Response to 25* CCQs
across multiple time points. Number of questionnaires completed by the child (excludes the puberty, CCXB and CCXC
subsample questionnaires). (c) Attendance at 9* child ‘Focus’ clinical assessment visits. Number of ‘Focus’ clinical as-
sessments attended by the child (excludes the CiF sub-sample clinics)










ALSPAC linkage to routine health and
administrative records
Information on individuals eligible to participate in
ALSPAC is currently available through linkage to the
ONS (deaths and cancer registrations, 99% coverage
of the ‘eligible sample’), the National Pupil Database
(82% coverage of the ‘eligible sample’ depending on
time point) and the General Practice Research
Database11 (4% coverage of the ‘eligible sample’).
The Project to Enhance ALSPAC through Record
Linkage (PEARL) is extending the use of linkage to
administrative data to enhance the ALSPAC data re-
source and address issues of possible participation
bias. Existing or intended administrative data sources
used by ALSPAC are listed in Table 8.
The use of ALSPAC as a sampling frame
The ALSPAC cohort has frequently been used to study
subpopulations and controls identified in a variety of
ways, including by genotype (e.g. smoking-related
genotypes used for recall of sample for detailed assess-
ment of smoking style), environment and/or pheno-
type. These have included qualitative projects (young
people’s views on record linkage, drug use in teenagers)
and quantitative projects (e.g. bone fractures,12 phys-
ical exercise13 and diet, children and siblings in families
with parental separation14). The ALSPAC sample has
also been used to select cases for inclusion in rando-
mized control trials including the value of thermom-
eters in a child’s nursery and comparisons between
two designs of orthoptic screening for visual defects
(as part of the CiF 4–37-month clinics).15
What has it found? Key findings
and publications
There have been4700 articles published by February
2012; details of these can be found on the ALSPAC
study website.16 A summary of some of the key
ALSPAC findings has recently been published else-
where.17 Notable examples of how ALSPAC findings
have informed health and social policy include the
following: (i) providing evidence to help persuade
policy makers to support the ‘back to sleep’ policy
change. This campaign started in the UK prior to
ALSPAC’s initiation, and initially advised parents
not to place their babies to sleep in the prone position
to reduce the risk of cot death. ALSPAC reassured
sceptical health professionals and policy makers to
proceed to recommending the supine position by
demonstrating that this position was not associated
Table 6 ALSPAC phenotype measures
Self-reported questionnaire measures (from pregnancy to the age of 18 years)
 Demographics: ethnicity
 Health: morbidity, accidents and injuries, medication
 Psychological and social: alcohol, smoking and illicit drug use, sexual behaviour, depression, significant life events,
parent peer and sibling relationships, peer networks, temperament and behaviour
 Development: puberty and menstruation, speech and language, fine and gross motor coordination
Education questionnaires and tests administered in school
 Understanding of mathematics and science (age 8, 11 and 14 years)
 Spelling
 School experiences and aspirations
 Teacher assessment of the child (age 8 and 11 years)
‘CiF’ clinical assessment measures [10 clinics (Supplementary Table S1, available as Supplementary data at IJE online),
10% subsample]
 Physiological: anthropometry, blood pressure and pulse rate, lung function, fitness, skin, eye and dental observations,
allergy testing, vision, tympanometry and hearing, speech and language
 Cognitive: speech and language, cognition (Griffiths test and WPSSIa)
‘Focus’ clinical assessment measures [nine clinics from the age of 7–17 years (Supplementary Table S1, available as
Supplementary data at IJE online), full ‘eligible sample’ invited, see recruitment earlier in this article]
 Physiological: anthropometry, blood pressure, bone mineralization, fat and lean mass using DXAa whole body and hip
scans, pQCTa leg scan, audiometry and tympanometry, lung function, vision, taste and smell, atopy (skin prick test)
 Cognitive: IQ (WISCa), motor skills, memory, reading ability
 Psychological and social: depression (CIS-Ra), gender behaviour, self-esteem, peer relationships, antisocial activities,
romantic relations (ESYTCa), alcohol and drug use, eating disorders
aWPPSI: Wechsler Preschool and Primary Scale of Intelligence, DXA: Dual-emission X-ray Absorptiometry bone mineral scan, pQCT:
Peripheral Quantitative Computed Tomography bone mineral scan, WISC: Wechsler Intelligence Scale for Children, CIS-R: Clinical
Interview Schedule Revised symptom score, ESYTC: Edinburgh Study of Youth Transitions and Crime questionnaire assessment










with factors detrimental to child health.18,19
This finding also helped to persuade the US
National Institutes of Health to carry out their own
‘Back to Sleep’ campaign that started in 2004. (ii) The
finding that the application of skin creams containing
peanut oil as a base ingredient to broken skin20,21
sensitized children to peanut allergy has led to some
manufacturers altering the composition of the creams
and the Committee on Safety in Medicines recom-
mending that warning labels be included on all me-
dicinal products containing peanut oil. (iii) ALSPAC
has contributed to the debate on the consumption of
fish during pregnancy. Established advice in the UK
and USA was that on balance the risks of consuming
toxins while eating more than two portions of fish per
week outweighed the known benefits of eating fish.
ALSPAC findings have influenced UK and US guide-
lines concerning fish consumption in pregnancy by
demonstrating that benefits to child behaviour and
verbal IQ,22 early development23 and visual stereoa-
cuity24 outweigh potential harm of neurotoxicity
from mercury and other sources of contamination.
(iv) Evidence from ALSPAC including the influence
of socio-economic position on life chances and aspir-
ations were used to support the Independent Review
on Poverty and Life Chances by Frank Field MP ‘The
Foundation Years: Preventing Poor Children becoming
Poor Adults’25 and the Marmot Review Fair Society,
Healthy Lives.26
Genetic investigations using the candidate approach
to studying gene variation and phenotypic outcome
have described the influence of the filaggrin gene
(FLG)27 on child susceptibility to atopic eczema and
asthma. ALSPAC was the largest follow-up sample in
the discovery that variation at the FTO28,29 gene is
associated with increased adiposity and predisposition
to obesity; using DXA assessment measures ALSPAC
showed that the association was only present for fat
mass and not lean mass. ALSPAC holds DNA col-
lected at multiple time points, allowing researchers
to explore DNA methylation and epigenetics.30,31 To
realize the full potential of the resource ALSPAC is
involved in genetic consortium studies including
UK10K and EGG (early growth genetics).
Environmental studies have explored the ante-
cedents of asthma where environmental exposures
Table 7 ALSPAC environmental measures
Self-reported questionnaire measures (from pregnancy to the age of 18 years)
 Diet: food frequency questions
 Housing: type of home, tenure, number of rooms, availability of facilities such as hot running water and central
heating
 Social background: social class based on parental occupations, parental educational level, type of neighbourhood, use
of car
 Household composition: with changes over time, crowding (person/room), pets
 Stressors: acute (measured with life events), conflict in the home, bullying/victimization at school, parental anxiety
and depression
 Medications, supplements and treatments
 Air pollutants: exposure to cigarette smoking, use of chemicals in the home, proximity to heavy traffic, types of
heating and cooking at home, ventilation
 Noise: exposure at home and at school
 Physical environment: time spent outdoors, methods of getting to school, time spent on various activities including
watching TV
 Safety equipment and measures taken in the home
 Type of school: school environment, day care, out of school care, school choice
‘Focus’ clinical assessment measures (nine clinics from the age of 7–17 years (Supplementary Table S1, available as
Supplementary data at IJE online), full ‘eligible sample’ invited, see recruitment earlier in this article)
 Physical activity: ‘actigraph’ activity accelerometers and ‘G4’ impact monitors
 Diet: using 3-day dietary diary
 Type of day care
Special studies of subsamples of homes
 Air pollutants within and outside the home
 Noise levels within the home
Using available census and local authority data
 Classification of housing band (for council tax)
 Proximity of home to power lines
 Linkage to deprivation level of neighbourhood










including prenatal maternal anxiety and paracetamol
use,32–34 exposure to a range of cleaning products35,36
and excessive hygiene regimens37 have been found to
influence the development of asthma in the child.
Analysis of early life influences including maternal
age, diet and smoking do not appear to influence
blood pressure in the child38–41 although maternal
weight gain in pregnancy is associated with
increased risk of child adiposity and adverse cardio-
vascular risk factors.42 ALSPAC has also shown that
fat mass contributes to higher bone mineral
density.43,44
What are the main strengths and
weaknesses?
The main strengths of ALSPAC are its general popu-
lation base and sample size, the breadth and fre-
quency of data collection and the availability of
repeat measures, the extensive biobank, the breadth
of genetic sampling and the ongoing support and
commitment from the study families.
ALSPAC also has some weaknesses. Despite its size,
it lacks power to study rarer exposures and outcomes.
Although ALSPAC has collected repeat measures
across frequent time points, the early (up to the age
of 5 years) collection of data at study assessment
clinics was limited to a 10% subsample.
Nevertheless, the data collected have been very in-
formative in regards to early growth and develop-
ment. Collecting data from young adults is
notoriously difficult and it is no surprise that
ALSPACs response rates have decreased over time.
To address this, ALSPAC is investing resources into
collecting data from health and administrative records
as well as participation initiatives aimed at increasing
response. Incomplete recruitment and subsequent at-
trition have further reduced power and the availability
of repeat measures across multiple time points and
may have introduced bias in relation to estimation
of some effects. Moreover, the demographic profile
of the catchment area population and the effects of
subsequent differential attrition have led to an over-
representation of more affluent groups and an
under-representation of non-White minority ethnic
groups compared with the national population. This
may influence external validity of some study findings
based on prevalence, although it should not influence
adversely the longitudinal results provided the fea-
tures affecting bias are included. An advantage of cur-
rent analyses is the relatively new statistical
techniques for taking account of missing data, and
these are being used increasingly.45
Table 8 ALSPAC linkage to health and administrative records
Health records
 aPrimary care electronic patient records
 bThe General Practice Research Database (GPRD)
 aHospital Episodes Statistics (HES), bCancer and Deaths Registry, NHS Information Centre and Office for National
Statistics
 bAd hoc data extraction from hospitals, bgeneral practice, bopticians and records of other health care providers (e.g.
records of childhood seizures)
Education records
 bSchool records; NPD schools data, Department for Education
 bFurther education and work-based learning; Individual Learner Record (ILR) database, Department for Business,
Innovations and Skills
 bHigher education; Higher Education Statistics Agency (HESA), Department for Business, Innovations and Skills
Economic, employment and social support (benefits) records
 Tax receipts and income; aWork and Pensions Longitudinal Survey (WPLS) database, Her Majesty’s Revenue and
Customs
 Receipt of benefits and pension provision; aWork and Pensions Longitudinal Survey (WPLS) database, Department for
Work and Pensions
Criminal convictions and cautions
 Criminal conviction or police cautions; aPolice National Computer (PNC) database, Ministry of Justice
Neighbourhood data
 Indices of Multiple Deprivation (of home residence)
 Townsend Score
aEither linkage, data owner approval and/or data collection mechanisms in development. bLinkage and data owner approvals in
place and data collected










Can I get hold of the data? Where
can I find out more?
Further details can be found on the ALSPAC website:
http://www.bristol.ac.uk/alspac/, including the full
ALSPAC collaboration policy (http://www.bristol.ac
.uk/alspac/documents/alspac-policy.pdf). This resource
also details all ALSPAC data (on mothers, index chil-
dren and other relatives) that are currently available
to external collaborators. At the present time, the
ALSPAC resource is set up as a supported access
resource rather than as an open access resource. In
brief, any researcher wanting to use ALSPAC data
must complete an ALSPAC Research Proposal Form
describing the proposed collaboration and send it to
the ALSPAC Executive (alspac-exec@bris.ac.uk). The
ALSPAC executive will reply, usually within 2 weeks,
to inform the applicant of the outcome and provide
advice on the next stages. The vast majority of re-
quests are approved as the system only checks avail-
ability of data and whether a cost will need to be
charged (in most cases <£1000) to cover the staff
resources required to put together a data set for col-
laborators. We do not police overlaps between re-
quests, but since July 2011 all approved projects are
detailed on the website (address as above), so poten-
tial collaborators can see what is already being done
with the resource. We also do not police the scientific
quality of projects, which is the responsibility of the
investigators, but we do ensure that the study is cor-
rectly described in articles/other reports going for pub-
lication. Once a project has been agreed, the
researchers are assigned a data buddy to support col-
laboration. The data buddy will provide the data set
and advice on analysis of the data set. Any newly
derived variables (including new assays on stored
bloods) by the collaborator will be put into the
main ALSPAC database and made available to other
researchers once the collaborator has completed their
project. As part of the collaborative agreement, we
expect collaborators to produce appropriately detailed
information about such new variables.
The ALSPAC executive plan to move towards more
open access collaboration in the future and details of
this will appear on the website. It is likely that access
to genetic (particularly GWAS) and molecular data
will have some supported access rather than being
completely open access. The access requirements and
use of external data collected through record linkage
will be determined by the contractual agreements
ALSPAC has with the data owners. Access to these
linkage data will be supported by ALSPAC.
Supplementary Data
Supplementary Data are available at IJE online.
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KEY MESSAGES
 ALSPAC evidence provided reassurance that the supine sleeping position in babies, recommended in
the ‘back to sleep’ campaign, did not appear to be detrimental to child health.18,19
 ALSPAC evidence on the influence of socio-economic position on life chances and aspirations has
contributed to reviews of UK national policy.25,26
 ALSPAC data combining a wide range of phenotypic and environmental data with genetic informa-
tion collected across multiple time points have allowed important contributions to genetic27–29 and
epigenetic epidemiology.30,31
 ALSPAC has provided important evidence on the influence of environmental exposures, such as
prenatal maternal paracetamol use and household cleaning products and hygiene regimens, on the
risk of asthma in the child.32–37
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